Analytical Data
-
Gene name
GPR15L
- Application
-
Alternative Names
Antimicrobial peptide with 57 amino acid residues (AP-57) (Antimicrobial peptide-57) (Colon-derived SUSD2 binding factor) (CSBF) (Secreted protein C10orf99) (C10orf99)
-
Species
Human
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6UWK7
-
Expression Region
25-81aa
-
Molecular Weight
14.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GPR15L, also known as G protein-coupled receptor 15-like, has garnered significant attention in recent years due to its role in immune response and potential implications in various diseases. This receptor, primarily expressed in immune cells, is involved in the regulation of inflammatory processes and lymphocyte trafficking. Research has indicated that GPR15L interacts with specific ligands, influencing T cell behavior and contributing to the pathogenesis of conditions such as autoimmune diseases and cancer. The study of GPR15L recombinant proteins is crucial for elucidating its structure-function relationships and signaling mechanisms. Understanding how GPR15L functions can pave the way for the development of targeted therapies aimed at modulating immune responses. Additionally, the production and characterization of GPR15L recombinant proteins facilitate the exploration of potential diagnostic and therapeutic applications, especially in immunotherapy. Given the increasing prevalence of immune-mediated disorders and the ongoing search for novel therapeutic targets, GPR15L represents a promising area of research that could lead to significant advancements in immunology and treatment strategies.
